罗格列酮:在研究表明心肌梗死风险增加导致推荐量改变后，我们应该如何使用这种口服降糖药?

{"title":"罗格列酮:在研究表明心肌梗死风险增加导致推荐量改变后，我们应该如何使用这种口服降糖药?","authors":"B. Karet","doi":"10.3132/PCCJ.2008.004","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":308856,"journal":{"name":"Primary Care Cardiovascular Journal (pccj)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Rosiglitazone: how should we be using this oral hypoglycaemic drug after studies indicating increased MI risk have resulted in changes in recommendations?\",\"authors\":\"B. Karet\",\"doi\":\"10.3132/PCCJ.2008.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":308856,\"journal\":{\"name\":\"Primary Care Cardiovascular Journal (pccj)\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Primary Care Cardiovascular Journal (pccj)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3132/PCCJ.2008.004\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Primary Care Cardiovascular Journal (pccj)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3132/PCCJ.2008.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}